Effectivity of Virtual Reality to Improve Balance, Motor Function, Activities of Daily Living, and Upper Limb Function in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
Publication Type
Original research
Authors
Fulltext
Download

Background: Cerebral palsy (CP) is the most common motor disorder in childhood. CP limits movement, which can interfere with children’s daily activities. As a technology that provides intensive mass practice to children, virtual reality (VR) can create an interactive and motivating environment. With the intensity set by the therapist and feedback that can be used to produce individualized therapy, VR has great potential to improve CP patients’ quality of life, especially in a safe, enjoyable, and playful environment.
Purpose: This systematic review and meta-analysis sought to determine the effectiveness of VR for children with CP.
Methods: We conducted a comprehensive literature search based on the PRISMA guidelines through PubMed, Scopus, Embase, Wiley, and ProQuest to assess the efficacy of VR in managing children with CP up to 15 September 2022. Risk assessment of bias was performed using Cochrane RoB 2.
Results: Nineteen randomized controlled trials with 467 and 427 patients with CP were included in the intervention and control groups in qualitative and quantitative analyses. Participants consisted of cerebral palsy with hemiplegia (n=7), diplegia (n=2), a combination of both (n=4), and undefined (n=13). From all studies conducted, VR showed significant results where VR could improve balance (MD: 2.71[1.95, 3.48]; p < 0.00001), motor function (MD: 3.73 [1.67, 5.79]; p = 0.0004), and activity daily living (MD: 10.05 [2.89, 17.22]. However, VR showed not effective in improving upper limb function.
Conclusion: With its advantages and excellent effectiveness, VR may improve functional mobility and the quality of life of children with CP.

Keywords: balance, cerebral palsy, children, motor function, virtual reality

Journal
Title
Therapeutics and Clinical Risk Management
Publisher
Dove Medical Press
Publisher Country
United Kingdom
Indexing
Scopus
Impact Factor
2.8
Publication Type
Both (Printed and Online)
Volume
2024
Year
2024
Pages
95—109